myBiometry
Boston, US · 6 known investors
Find your way into myBiometry
MyBiometry offers a patented at-home sensor and device that measures airway inflammation through fractional exhaled nitric oxide (FeNO) in a person's breath. The biomarker data is used to assess attack risk, medication adherence and efficacy, and exposure to environmental triggers for respiratory conditions.
Founders & leadership
BN
Bryan NolanFounder
Investors · 6
Bantam GroupWestwood
Boston Harbor AngelsBoston · $250K – $1.5M
Elevate VenturesIndianapolis · $20K – $2M
Launchpad Venture GroupBoston · $8M – $10M
Also in the syndicate · 2
CareSource IndianaDexcom Ventureslead
Funding
SEC filings, press & company announcements$5M disclosed across 1 round · 2024
- $5MSeed RoundNov 2024 · 5 sources
Dexcom Ventures (lead), CareSource Indiana, Elevate Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does myBiometry do?
- MyBiometry offers a patented at-home sensor and device that measures airway inflammation through fractional exhaled nitric oxide (FeNO) in a person's breath. The biomarker data is used to assess attack risk, medication adherence and efficacy, and exposure to environmental triggers for respiratory conditions.
- Who founded myBiometry?
- myBiometry was founded by Bryan Nolan.
- Who are myBiometry's investors?
- myBiometry's investors include Bantam Group, Boston Harbor Angels, Elevate Ventures, Launchpad Venture Group.
- How much funding has myBiometry raised?
- myBiometry has disclosed $5M raised across 1 round.
- Where is myBiometry headquartered?
- myBiometry is headquartered in Boston, US.